20002019
If you made any changes in Pure these will be visible here soon.

Fingerprint The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.

  • 41 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Cells Chemical Compounds
Neoplasms Medicine & Life Sciences
Germinal Center Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Genes Medicine & Life Sciences
B-Lymphocyte Subsets Medicine & Life Sciences

Network Dive into details by clicking on the dots.

Research Output 2000 2019

51 Downloads (Pure)

Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis

Jespersen, D. S., Schönherz, A. A., Due, H., Bøgsted, M., Sondergaard, T. E. & Dybkær, K., Jan 2019, In : Scientific Reports. 9, 1, 335.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Lymphoma, Large B-Cell, Diffuse
Exons
Biomarkers
Vincristine
Genes

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients

Laursen, M. B., Reinholdt, L., Schönherz, A. A., Due, H., Jespersen, D. S., Grubach, L., Ettrup, M. S., Røge, R., Falgreen, S., Sørensen, S., Bødker, J. S., Schmitz, A., Johnsen, H. E., Bøgsted, M. & Dybkær, K., Jan 2019, In : Oncotarget. 10, 7, p. 717-731 15 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Lymphoma, Large B-Cell, Diffuse
Rituximab
Cell Line
Cell Surface Receptors
B-Lymphocytes

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodríguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkær, K., Tam, W., You, H., Bhagat, G., Hsi, E. D. & 13 othersPonzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., van Krieken, J. H., Winter, J. N., Westin, J. R., Pham, L. V., Medeiros, L. J., Rassidakis, G. Z., Li, Y., Freeman, G. J. & Young, K. H., 1 Apr 2019, In : Cancer Immunology Research. 7, 4, p. 644-657 14 p.

Research output: Contribution to journalJournal articleResearchpeer-review

MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma

Due, H., Schönherz, A. A., Ryø, L., Primo, M. N., Jespersen, D. S., Thomsen, E. A., Roug, A. S., Xiao, M., Tan, X., Pang, Y., Young, K. H., Bøgsted, M., Mikkelsen, J. G. & Dybkær, K., Apr 2019, In : Blood advances. 3, 7, p. 1185-1196 12 p.

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
Lymphoma, Large B-Cell, Diffuse
Vincristine
MicroRNAs
Germinal Center
B-Lymphocytes

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Li, L., Sun, R., Miao, Y., Tran, T., Adams, L., Roscoe, N., Xu, B., Manyam, G. C., Tan, X., Zhang, H., Xiao, M., Tzankov, A., Visco, C., Dybkaer, K., Bhagat, G., Tam, W., Hsi, E. D., van Krieken, J. H., You, H., Huh, J. & 13 othersPonzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Zhang, M., Winter, J. N., Medeiros, L. J., Rassidakis, G. Z., Vaupel, C. A., Li, Y., Dakappagari, N., Xu-Monette, Z. Y. & Young, K. H., 21 Jan 2019, In : Modern Pathology. 14 p.

Research output: Contribution to journalJournal articleResearchpeer-review

T-Cell Lymphoma
B-Lymphocytes
Lymphoma, Large B-Cell, Diffuse
T-Lymphocytes
Programmed Cell Death 1 Receptor

Activities 2010 2012

  • 11 Organisation or participation in workshops, courses, or seminars
  • 5 Membership of committees, commissions, boards, councils, associations, organisations, or similar
  • 3 Talks and presentations in private or public companies
  • 1 Conference organisation or participation

ASH 2010 - American Society of Hematology

Karen Dybkær (Participant)
4 Dec 20107 Dec 2010

Activity: Attending an eventOrganisation or participation in workshops, courses, or seminars

Blood and Biomarkers

Karen Dybkær (Participant)
20 Apr 2010

Activity: Attending an eventOrganisation or participation in workshops, courses, or seminars

Dansk Biokemisk Forening (External organisation)

Karen Dybkær (Member)
1 Jan 2011 → …

Activity: MembershipsMembership of committees, commissions, boards, councils, associations, organisations, or similar

Dansk Hæmatologisk Selskab (External organisation)

Karen Dybkær (Member)
1 Jan 2011 → …

Activity: MembershipsMembership of committees, commissions, boards, councils, associations, organisations, or similar

Dansk Hæmatologisk Selskabs Vårmøde

Karen Dybkær (Participant)
19 Mar 201020 Mar 2010

Activity: Attending an eventOrganisation or participation in workshops, courses, or seminars

Press / Media

Mindeord

Karen Dybkær, Martin Bøgsted & Søren Pihlkjær Hjortshøj

26/05/2018

2 items of media coverage

Press/Media: Press / Media

Bedre behandling af lymfeknudekræft på vej

Karen Dybkær, Martin Bøgsted & Hans Erik Johnsen

04/11/2015

1 item of media coverage

Press/Media: Press / Media

Læger er nødt til at behandle med kemo, som de ved ikke hjælper

Karen Dybkær

24/04/2015

1 item of media coverage

Press/Media: Press / Media